Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.
Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
Providence Cancer Institute registered dietitian to present a free virtual education talk on nutrition in March.
Providence and Regence have reached an agreement to continue care delivery services together.
New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.
Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.